Simplex Trading’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Sell
66,432
-10,783
-14% -$47.6K ﹤0.01% 4323
2026
Q1
$279K Sell
77,215
-3,350
-4% -$11.6K ﹤0.01% 3905
2025
Q4
$275K Buy
80,565
+40,186
+100% +$195K ﹤0.01% 3907
2025
Q3
$274K Sell
40,379
-58,505
-59% -$483K ﹤0.01% 4589
2025
Q2
$1.35M Buy
+98,884
New +$934K ﹤0.01% 2479
2024
Q4
Sell
-40,141
Closed -$210K 9135
2024
Q3
$210K Buy
40,141
+3,502
+10% +$20.2K ﹤0.01% 4473
2024
Q2
$251K Buy
+36,639
New +$335K ﹤0.01% 4425
2023
Q3
Sell
-2,190
Closed -$9.49K 9287
2023
Q2
$9K Buy
2,190
+964
+79% +$2.14K ﹤0.01% 7498
2023
Q1
$2K Sell
1,226
-3,234
-73% -$5.71K ﹤0.01% 8477
2022
Q4
$8K Buy
+4,460
New +$10K ﹤0.01% 7732
2022
Q2
Sell
-864
Closed -$2.15K 10570
2022
Q1
$3K Sell
864
-4,344
-83% -$15.4K ﹤0.01% 9714
2021
Q4
$20K Sell
5,208
-44,693
-90% -$211K ﹤0.01% 8358
2021
Q3
$578K Buy
49,901
+400
+0.8% +$3.41K ﹤0.01% 3869
2021
Q2
$583K Buy
+49,501
New +$570K ﹤0.01% 3913

Other funds holding LFMD

Simplex Trading's LFMD Position: Q2 2026 in Review

Simplex Trading reduced its LifeMD (LFMD) stake by 14% in Q2 2026, selling an estimated $47.6K and leaving 66,432 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #4323.

Simplex Trading first reported a position in LFMD in Q2 2021 and has held it in 14 quarters since. The position peaked at $1.35M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Simplex Trading held 66,432 shares of LifeMD worth $274K as of Q2 2026.
  • Simplex Trading sold 10,783 LifeMD shares in Q2 2026, an estimated $47.6K.
  • LifeMD made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4323 holding.
  • Simplex Trading first reported a position in LifeMD in Q2 2021 and has held it in 14 quarters since.
  • Simplex Trading's LifeMD position peaked at $1.35M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.